Which stocks are best to buy now? According to top Wall Street analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.
To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by top-ranking analysts.
Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.
Biomea Fusion (NASDAQ:BMEA) – The biopharma company is focused on developing irreversible small-molecule drugs for genetically defined cancer treatment. Today, Citi analyst Yigal Nochomovitz maintained a Buy rating on the stock with a price target of $90. Overall, the consensus 12-month price target of all four top analysts who recently rated the stock a Buy, implies an upside of 75.25%.
Syndax Pharmaceuticals (NASDAQ:SNDX) – Syndax is a clinical-stage biotech firm working on cancer treatments. Yesterday, BTIG analyst Justin Zelin assigned a Buy rating on the stock with a price target of $35. Overall, the consensus 12-month price target of all five top analysts who recently rated the stock a Buy, implies an upside of nearly 60%.
Agnico Eagle Mines (NYSE:AEM) – Agnico is a Canada-based gold mining company. Today, analyst Emily Chieng of Goldman Sachs reiterated a Buy rating on the stock with a $65.80 price target. Overall, the consensus 12-month price target of all four top analysts who recently rated the stock a Buy, implies an upside of 34.23%.
Who are the Top Analysts?
TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. See real-time analyst rankings and learn more about the performance of top analysts on TipRanks’ Top Wall Street Analysts page.
